Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma.

ABSTRACT:

SUBMITTER: Palfi S 

PROVIDER: S-EPMC11997198 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature